Literature DB >> 8982367

Immunosuppressive cytokines (IL-10, TGF-beta) genes expression in human gastric carcinoma tissues.

T Morisaki1, M Katano, A Ikubo, K Anan, M Nakamura, K Nakamura, H Sato, M Tanaka, M Torisu.   

Abstract

BACKGROUND: Contribution of immunosuppressive cytokines to tumor progression in many types of cancers has been suggested. To characterize the in vivo expression of immunosuppressive cytokines in gastric cancer, we analyzed the messenger RNA (mRNA) expression of transforming growth factor-beta (TGF-beta) and interleukin-10 (IL-10) in human gastric carcinoma tissues.
METHODS: Both tumor tissues and nontumor tissues from each resected specimen of 29 primary gastric carcinomas were tested for IL-10 and TGF-beta mRNA expression by the reverse transcriptase-polymerase chain reaction (RT-PCR), and the mRNA expression was correlated with various pathological parameters of the tumors.
RESULTS: Among the 29 tumors, mRNAs of TGF-beta and IL-10 were detected in 79% and 62% of tumor samples, respectively. These cytokines were detected only in 31% for TGF-beta and 17% for IL-10 in nontumor samples. Both mRNAs were frequently expressed in the poorly differentiated adenocarcinomas and the tumor tissues with high degree of stage or lymph node metastasis.
CONCLUSIONS: Local expression of immunosuppressive cytokines may contribute to the progression of primary gastric carcinomas possibly through immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982367     DOI: 10.1002/(SICI)1096-9098(199612)63:4<234::AID-JSO4>3.0.CO;2-D

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas.

Authors:  Maria D Begnami; Andre L Montagnini; Andre L Vettore; Sueli Nonogaki; Mariana Brait; Alex Y Simoes-Sato; Andrea Q A Seixas; Fernando A Soares
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

2.  Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation.

Authors:  Pachiappan Arjunan; Mohamed M Meghil; Wenhu Pi; Jinxian Xu; Liwei Lang; Ahmed El-Awady; William Sullivan; Mythilypriya Rajendran; Mariana Sousa Rabelo; Tong Wang; Omnia K Tawfik; Govindarajan Kunde-Ramamoorthy; Nagendra Singh; Thangaraju Muthusamy; Cristiano Susin; Yong Teng; Roger M Arce; Christopher W Cutler
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

Review 3.  Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

Authors:  Hironori Tsujimoto; Satoshi Ono; Takashi Ichikura; Yusuke Matsumoto; Junji Yamamoto; Kazuo Hase
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

Review 4.  A user's perspective on GeoMxTM digital spatial profiling.

Authors:  Trieu My Van; Christian U Blank
Journal:  Immunooncol Technol       Date:  2019-05-30

5.  IL-32 expression is an independent prognostic marker for gastric cancer.

Authors:  Sumiya Ishigami; Takaaki Arigami; Yasuto Uchikado; Tetsuro Setoyama; Yoshiaki Kita; Ken Sasaki; Hiroshi Okumura; Hiroshi Kurahara; Yuko Kijima; Aya Harada; Shinichi Ueno; Shoji Natsugoe
Journal:  Med Oncol       Date:  2013-03-12       Impact factor: 3.064

6.  Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.

Authors:  Sean Marrache; Joshua H Choi; Smanla Tundup; Dhillon Zaver; Donald A Harn; Shanta Dhar
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

Review 7.  Gene therapy for carcinoma of the breast: Genetic immunotherapy.

Authors:  T V Strong
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

Review 8.  Immune selection in neoplasia: towards a microevolutionary model of cancer development.

Authors:  S J Pettit; K Seymour; E O'Flaherty; J A Kirby
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 9.  Potential mechanisms of tumor progression associated with postoperative infectious complications.

Authors:  Hironori Tsujimoto; Minako Kobayashi; Hidekazu Sugasawa; Satoshi Ono; Yoji Kishi; Hideki Ueno
Journal:  Cancer Metastasis Rev       Date:  2021-01-03       Impact factor: 9.264

10.  Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma.

Authors:  M Nakamura; M Katano; A Kuwahara; K Fujimoto; K Miyazaki; T Morisaki; M Mori
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.